Trial NCT02862574

View at ClinicalTrials.gov 
Org. Study IDs: GS-US-373-1499
Secondary IDs: 2016-000897-39

Last trial update was posted on 2018-06-27

MeSH Interventions

Methotrexate Tumor Necrosis Factor Inhibitors

MeSH Conditions

Arthritis Arthritis, Rheumatoid Necrosis

Other Conditions

Rheumatoid Arthritis

Stopping Reasons

Study was terminated by sponsor and decision was not due to any safety signals.

Limitations And Caveats

Gilead decided to discontinue the development of andecaliximab in RA and this study was terminated. The decision was not due to any safety concerns. Because only 15 participants were enrolled, no formal statistical testing was completed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID